Site web: https://www.mybiotec.com/

Numéro de stand : D129

Catégorie

• Injectables: Biostimulateurs
• Cosmeceutics - Produits anti-âge
• Injectables: Biostimulateurs

Profil de l'entreprise

Founded in 2018, Shanghai Moyom Biotechnology Co., Ltd. is a National High-tech Enterprise dedicated to innovation in regenerative medicine and biomaterials. Its flagship aesthetics brand, Aphranel®, was inspired by the founders’ pursuit of artistic beauty and life sciences. As the first original CaHA-based injectable filler approved by NMPA in China, Aphranel® has also obtained EU MDR certification and MDSAP compliance. As one of the leading brands in regenerative aesthetics, Aphranel® pioneered the precise control of CaHA microsphere particle size, porosity, and degradation rate. Supported by its safety profile, complete biodegradation, and regenerative mechanism, Aphranel® has earned growing recognition and trust from experts and patients worldwide. Guided by the mission of returning aesthetic medicine to its scientific and medical foundation, Moyom Biotechnology continues to drive innovation through science, empower clinical practice through academic education and professional support.